Multiple Sclerosis, MS, CNS, Daclizumab
Showing 26 - 50 of >10,000
Multiple Sclerosis (MS) Trial in Birmingham (Physical activity behavioral intervention in persons newly diagnosed with MS)
Recruiting
- Multiple Sclerosis (MS)
- Physical activity behavioral intervention in persons newly diagnosed with MS
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 24, 2023
Multiple Sclerosis Trial in San Francisco, Cleveland (Multiple Sclerosis Clinical Care Delivery via telehealth, Multiple
Not yet recruiting
- Multiple Sclerosis
- Multiple Sclerosis Clinical Care Delivery via telehealth
- Multiple Sclerosis Clinical Care Delivery via standard in clinic visits
-
San Francisco, California
- +1 more
Jan 3, 2023
MS Using a Mobile Application
Enrolling by invitation
- Multiple Sclerosis
- BeCare Mobile App
-
New York, New YorkWeill Cornell Medical College
Dec 22, 2022
Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis Trial in Belgium (Metformin
Not yet recruiting
- Multiple Sclerosis
- +2 more
- Metformin Hydrochloride 850 mg Oral Tablet
- Placebo
-
Brugge, Belgium
- +4 more
May 30, 2023
Multiple Sclerosis Trial in Worldwide (MSCopilot® mobile application)
Not yet recruiting
- Multiple Sclerosis
- MSCopilot® mobile application
-
Oklahoma City, Oklahoma
- +6 more
Apr 3, 2023
Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco
Not yet recruiting
- Multiple Sclerosis (MS)
- +6 more
- Clemastine Fumarate
- Placebo
-
San Francisco, CaliforniaSandler Neurosciences Building, Neurological Clinical Research U
Jan 23, 2023
Multimodal Imaging Signatures of Biological Mechanisms
Not yet recruiting
- Multiple Sclerosis (MS)
- MRI
- (no location specified)
Jan 12, 2023
Multiple Sclerosis, Balance, Cognitive Impairment Trial in Roma (Technological rehabilitation)
Not yet recruiting
- Multiple Sclerosis
- +2 more
- Technological rehabilitation
-
Roma, RM, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Aug 10, 2023
Multiple Sclerosis Trial in Boston (Truvada (tenofovir/emtricitabine))
Enrolling by invitation
- Multiple Sclerosis
- Truvada (tenofovir/emtricitabine)
-
Boston, MassachusettsMassachusetts General Hospital
Jul 14, 2023
Long-Term Safety of Vumerity and Tecfidera in Multiple Sclerosis
Not yet recruiting
- Multiple Sclerosis
- Diroximel Fumarate
- +2 more
- (no location specified)
Mar 2, 2023
Multiple Sclerosis Trial in Chicago (Exercise Training Program, Flexibility Program)
Not yet recruiting
- Multiple Sclerosis
- Exercise Training Program
- Flexibility Program
-
Chicago, IllinoisUniversity of Illinois at Chicago
Aug 9, 2023
Multiple Sclerosis Trial in Samsun (psychotherapeutic intervention)
Not yet recruiting
- Multiple Sclerosis
- psychotherapeutic intervention
-
Samsun, TurkeySAMSUN
Apr 24, 2023
Multiple Sclerosis Trial in New York (Active tDCS, Sham () stimulation)
Recruiting
- Multiple Sclerosis
- Active tDCS
- Sham (placebo) stimulation
-
New York, New YorkNew York University School of Medicine
Dec 28, 2022
Multiple Sclerosis Trial (Cognitive training, Motor training)
Recruiting
- Multiple Sclerosis
- Cognitive training
- Motor training
-
Brussel, Belgium
- +1 more
Nov 4, 2022
Magnetic Resonance Imaging to Evaluate Activity of Multiple
Recruiting
- Multiple Sclerosis
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 30, 2023
MS (Multiple Sclerosis) Trial in Bursa (Deep sensory assisted rehabilitation, classical rehabilitation)
Active, not recruiting
- MS (Multiple Sclerosis)
- Deep sensory assisted rehabilitation
- classical rehabilitation
-
Bursa, Yildirim, Turkey
- +1 more
Aug 7, 2023
Multiple Sclerosis Trial in Bordeaux (Anti-Mullerian hormone (AMH) level, Antral follicle count (AFC), Clinical assessment)
Not yet recruiting
- Multiple Sclerosis
- Anti-Mullerian hormone (AMH) level
- +2 more
-
Bordeaux, FranceCHU de Bordeaux - service de neurologie
Mar 6, 2023
Immunoglobulin DeficiencyTreatable Cause of Fatigue in Multiple
Recruiting
- Hypogammaglobulinemia
- +2 more
- Laboratory test
-
Bern, BE, SwitzerlandUniversity Hospital of Bern Inselspital
Sep 26, 2022
The MS-LINK™ Outcomes Study
Recruiting
- Multiple Sclerosis
-
Birmingham, Alabama
- +5 more
Nov 17, 2022
Neurogenic Bladder, Multiple Sclerosis, Voiding Dysfunction Trial in Houston (Magstim Rapid2 System)
Recruiting
- Neurogenic Bladder
- +2 more
- Magstim Rapid2 System
-
Houston, TexasHouston Methodist Hospital
Oct 3, 2023
Multiple Sclerosis Trial in Amsterdam (Strenghtening the brain, Strengthening the mind)
Recruiting
- Multiple Sclerosis
- Strenghtening the brain
- Strengthening the mind
-
Amsterdam, NetherlandsAmsterdam University Medical Centers, location VUmc
Oct 10, 2023
Older Adults, Multiple Sclerosis, Cognitive Impairment Trial in Chicago (Aerobic and Resistance Exercise Program (GEMS program),
Recruiting
- Older Adults
- +3 more
- Aerobic and Resistance Exercise Program (GEMS program)
- Flexibility and Stretching Program (FLEX-MS program)
-
Chicago, IllinoisUniversity of Illinois at Chicago
Jul 5, 2023
Turkish Version of F-2-MS
Not yet recruiting
- Cultural Adaptation
- +4 more
- Cultural adaptation, reliability and validity
- (no location specified)
Oct 19, 2022